Cargando…
How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
Despite significant advances in therapeutic possibilities for the treatment of inflammatory bowel disease (IBD) in recent years, there is still a big room for improvement. In particular, biological treatment can induce not only clinical remission but also mucosal healing of the gastrointestinal trac...
Autores principales: | Eder, Piotr, Zielińska, Aleksandra, Karczewski, Jacek, Dobrowolska, Agnieszka, Słomski, Ryszard, Souto, Eliana B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554748/ https://www.ncbi.nlm.nih.gov/pubmed/34715852 http://dx.doi.org/10.1186/s12951-021-01090-1 |
Ejemplares similares
-
Obesity and the Brain
por: Karczewski, Jacek, et al.
Publicado: (2022) -
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review
por: Zielińska, Aleksandra, et al.
Publicado: (2023) -
Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2021) -
NGS study of glucocorticoid response genes in inflammatory bowel disease patients
por: Skrzypczak-Zielinska, Marzena, et al.
Publicado: (2019) -
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)